Guanoxabenz

This classification denotes an alpha-adrenergic agonist with the molecular formula C8H8Cl2N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P9HIK5V7WK, chemically known as 1-((2,6-dichlorobenzylidene)amino)-3-hydroxyguanidine but generally known as guanoxabenz, which bears US NIH Compound Identifier 9567831. European Medicines Agency schedules Guanoxabenz in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14038MIG. The term GUANOXABENZ is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). World Health Organization schedules guanoxabenz in its Anatomical Therapeutic Chemical (ATC) Classification. GUANOXABENZ is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule guanoxabenz under HS 29280090 and SITC 51486. As of Q4 2014, GUANOXABENZ remains the US FDA Preferred Term for this commodity. Guanoxabenz bears US NLM identifiers UMLS ID C0061990 and NCI Concept Code C77298. SMILES: CLC1C(C(CL)CCC1)/C=N/N=C(/NO)N.